Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Trazodone
Drug ID BADD_D02266
Description Trazodone is triazolopyridine derivative from the serotonin receptor antagonists and reuptake inhibitors (SARIs) class of antidepressants.[A181180] It is used in adults and has been shown to be comparable in efficacy to other drugs such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine receptor inhibitor (SNRIs) in the treatment of depression.[T646] A unique feature of this drug is that it does not promote the anxiety symptoms, sexual symptoms, or insomnia, which are commonly associated with SSRI and SNRI therapy.[T646] Trazodone acts on various receptors, including certain histamine, serotonin, and adrenergic receptors, distinguishing it from other antidepressants that cover a narrow range of neurotransmitters.[T646] It was initially granted FDA approval in 1981.[L3484]
Indications and Usage For the treatment of depression.
Marketing Status Prescription; Discontinued
ATC Code N06AX05
DrugBank ID DB00656
KEGG ID D08626
MeSH ID D014196
PubChem ID 5533
TTD Drug ID D00USF
NDC Product Code 51655-634
Synonyms Trazodone | Tradozone | AF-1161 | AF 1161 | AF1161 | Deprax | Desyrel | Gen-Trazodone | Gen Trazodone | Molipaxin | Novo-Trazodone | Novo Trazodone | Trittico | PMS-Trazodone | PMS Trazodone | Ratio-Trazodone | Ratio Trazodone | RatioTrazodone | Thombran | Trazodon Hexal | Trazodon-Neuraxpharm | Trazodon Neuraxpharm | TrazodonNeuraxpharm | Trazodone Hydrochloride | Trazon | Apo-Trazodone | Apo Trazodone | Nu-Trazodone | Nu Trazodone
Chemical Information
Molecular Formula C19H22ClN5O
CAS Registry Number 19794-93-5
SMILES C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Poisoning and toxicityCytochrome P450 2D6P10635T57392Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Sticky skin23.03.03.019--Not Available
Eye pruritus06.04.05.006--Not Available
Musculoskeletal stiffness15.03.01.005--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Inappropriate antidiuretic hormone secretion14.05.07.001; 05.03.03.0010.000090%Not Available
Electrocardiogram PR prolongation13.14.05.012--Not Available
Congestive cardiomyopathy02.04.01.003--Not Available
Gastric disorder07.11.01.003--Not Available
Cognitive disorder19.21.02.001; 17.03.03.003--
Vasodilation procedure25.03.01.001--Not Available
Disturbance in sexual arousal19.08.04.003--Not Available
Lactation disorder21.05.02.004; 18.06.02.003--
Motor dysfunction17.02.10.004--Not Available
Decreased appetite08.01.09.028; 14.03.01.005--
Erectile dysfunction21.03.01.007; 19.08.04.0010.000090%
Ill-defined disorder08.01.03.049--Not Available
Urinary tract obstruction20.08.01.004--
Psychotic disorder19.03.01.002--
Poor quality sleep19.02.05.005; 17.15.04.002--Not Available
Hepatic enzyme abnormal13.03.01.020--Not Available
The 7th Page    First    Pre   7    Total 7 Pages